Docosatrienoic Acid Inhibits Melanogenesis Partly through Suppressing the Intracellular MITF/Tyrosinase Axis
Pharmaceuticals · 11.09.2024 · 17 (9) · 1198
DOI: 10.3390/ph17091198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 11.09.2024. Verfasst von Kyoung Mi Moon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Nutrition, Pukyong National University, Busan 48513, Republic of Korea. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF) grant, Pukyong National University Industry-university Cooperation Research Fund in 2023, Pukyong National University Industry–University Cooperation Research Fund.
Abstract (Originalsprache)
Melanogenesis, essential for skin photoprotection and pigmentation, can lead to disorders like melasma and hyperpigmentation, which are challenging to treat and affect quality of life. Docosatrienoic acid (DTA), a polyunsaturated omega-3 fatty acid, has been identified as a potential regulator of skin aging. This study investigates DTA’s effects on melanogenesis and its underlying molecular mechanisms using in silico and in vitro analyses. SwissSimilarity analysis revealed that DTA shares close structural similarities with known anti-melanogenic lipids, suggesting it may inhibit melanogenesis in similar manners. Our results demonstrated that DTA reduces melanin content and intracellular tyrosinase activity in B16F10 cells, significantly downregulating the mRNA expression of tyrosinase, TRP-1, and TRP-2 by inhibiting MITF translocation to the nucleus. While DTA exhibited mild inhibitory effects on mushroom tyrosinase activity and antioxidant properties at higher concentrations, direct inhibition of tyrosinase is likely not the primary mechanism, as the observed anti-melanogenic effects occurred at much lower concentrations compared to those required for direct tyrosinase inhibition. Together, DTA-mediated modulation of MITF and tyrosinase mRNA expression offers a novel approach to treating hyperpigmentation. DTA’s potential extends into the cosmetic industry, enhancing product stability, functionality, and aesthetics. Further research is needed to explore DTA’s broader applications in skincare and cosmetic formulations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Food Science and Nutrition, Pukyong National University, Busan 48513, Republic of Korea.
- Biotechnology Research Division, National Institute of Fisheries Science, Busan 48513, Republic of Korea.
- Department of Smart Green Technology Engineering, Pukyong National University, Busan 48513, Republic of Korea.
- Marine Integrated Biomedical Technology Center, The National Key Research Institutes, Pukyong National University, Busan 48513, Republic of Korea.
ORCID-Profile: Su-Yeon Park
Förderung
- National Research Foundation of Korea (NRF) grant
- Pukyong National University Industry-university Cooperation Research Fund in 2023
- Pukyong National University Industry–University Cooperation Research Fund
- National Research Foundation of Korea (NRF) grant funded by the Ministry of Education
Zitieren
APA
Moon, K. M., Lee, M. K., Park, S. Y., Seo, J., Kim, A. R., & Lee, B. (2024). Docosatrienoic Acid Inhibits Melanogenesis Partly through Suppressing the Intracellular MITF/Tyrosinase Axis. Pharmaceuticals, 17(9), 1198. https://doi.org/10.3390/ph17091198
Vancouver
Moon KM, Lee MK, Park SY, Seo J, Kim AR, Lee B. Docosatrienoic Acid Inhibits Melanogenesis Partly through Suppressing the Intracellular MITF/Tyrosinase Axis. Pharmaceuticals. 2024;17(9):1198. doi:10.3390/ph17091198
BibTeX
@article{Moon2024,
author = {Moon, Kyoung Mi and Lee, Min-Kyeoun and Park, Su-Yeon and Seo, Jaeseong and Kim, Ah-Reum and Lee, Bonggi},
title = {Docosatrienoic Acid Inhibits Melanogenesis Partly through Suppressing the Intracellular MITF/Tyrosinase Axis},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {9},
pages = {1198},
doi = {10.3390/ph17091198}
}
EUVIMED